跳至主要内容
临床试验/NCT06874465
NCT06874465招募中不适用

TAVI Registry at the National Research Center for Cardiac Surgery, Astana, Kazakhstan

National Research Center for Cardiac Surgery, Kazakhstan2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年1月10日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
2
主要终点
Number of death

研究概览

简要总结

This study will analyze patients with aortic stenosis who have undergone transcatheter valve implantation and surgical aortic valve replacement. Afterwards, the results of these two procedures will be collected to the database and compared among the Kazakhstani population.

详细描述

Primary Objectives

  1. Prevalence of aortic stenosis in Kazakhstan regions
  2. 12 months survival of patients after TAVI
  3. Intra- and postoperative complications
  4. Conduction disorders after TAVI
  5. Left ventricle function after TAVI in patients with low ejection fraction
  6. Comparison of aortic route dimensions by 3D-TEE and MSCT
  7. Comparison of TAVR with SAVR

Study Design Registry, IV phase

Subject Follow-up Schedule Maximum follow-up is approximately 4 years.

Inclusion Criteria Patients have TAVI

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients has given written informed Concent for study participation prior to procedure
  • Patients with Aortic Valve stenosis
  • Patients has severe degenerative or congenital aortic stenosis.
  • Patients has symptomatic aortic stenosis as demonstrated by NYHA II or greater

排除标准

  • Patients has active endocarditis
  • Patients has history of cerebral vascular accident or transient ischemic attack within the past 3 months

结局指标

主要结局

Number of death

时间窗: 1 year

12 month all-cause of mortality

Incidence of stroke

时间窗: within 30 days and 12 months

procedure associated stroke and 12 months

Permanent pacemaker implantation

时间窗: within 30 days

procedure associated AB block which is need for permanent pacemaker implantation

Evaluate of echocardiographic results

时间窗: 1 year

echocardiographic parameters: Aortic valve orifice area, aortic valve bioprosthetic gradient (peak, mean), aortic valve bioprosthetic velocity, ejection fracrion of left ventricle (LVEF%).

次要结局

  • Life quality(Baseline, 12 months)

研究者

发起方
National Research Center for Cardiac Surgery, Kazakhstan
申办方类型
Other
责任方
Principal Investigator
主要研究者

Abdurashid

Head of the department of the catheterization laboratory

National Research Center for Cardiac Surgery, Kazakhstan

研究点 (2)

Loading locations...

相似试验